Read + Share
Poterala JE, Wisinski KB. Abbreviated endocrine therapy duration for low estrogen receptor-positive breast
cancer: The counter to extended endocrine therapy. Cancer 2022 Feb 25. doi: 10.1002/cncr.34158.
PMID: 35213039
|
 |
|
Poterala JE, Wisinski KB. Abbreviated endocrine therapy duration for low estrogen receptor-positive breast
cancer: The counter to extended endocrine therapy. Cancer 2022 Feb 25. doi: 10.1002/cncr.34158.
PMID: 35213039
|
|
|
|